Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4112556
Max Phase: Preclinical
Molecular Formula: C23H25N3O5
Molecular Weight: 423.47
Molecule Type: Small molecule
Associated Items:
ID: ALA4112556
Max Phase: Preclinical
Molecular Formula: C23H25N3O5
Molecular Weight: 423.47
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N#Cc1nc(C(=O)NCC2(C(=O)O)CCC2)c(O)c2ccc(OC3CCCCC3)cc12
Standard InChI: InChI=1S/C23H25N3O5/c24-12-18-17-11-15(31-14-5-2-1-3-6-14)7-8-16(17)20(27)19(26-18)21(28)25-13-23(22(29)30)9-4-10-23/h7-8,11,14,27H,1-6,9-10,13H2,(H,25,28)(H,29,30)
Standard InChI Key: IVNASAIOJNMRBM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 423.47 | Molecular Weight (Monoisotopic): 423.1794 | AlogP: 3.51 | #Rotatable Bonds: 6 |
Polar Surface Area: 132.54 | Molecular Species: ACID | HBA: 6 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.20 | CX Basic pKa: | CX LogP: 4.23 | CX LogD: -0.35 |
Aromatic Rings: 2 | Heavy Atoms: 31 | QED Weighted: 0.65 | Np Likeness Score: -0.20 |
1. (2016) 4-hydroxy-isoquinoline compounds as HIF hydroxylase inhibitors, |
Source(1):